1 recruiting, 1 suspended, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 1, Suspended 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow T-Cell Therapy: new trials by email Literature Review of T-Cell Therapy trials Research Report on T-Cell Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML DC/AML Fusion Vaccine, T-Cell Therapy, Decitabine - Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse | Phase 1 | Recruiting | David Avigan | 30 | 2026-02-12 | 2026-05-05 |
| Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab - HER2-positive Breast Cancer | Phase 1 | Suspended | H. Lee Moffitt Cancer Center and Research Institute | 28 | 2022-05-31 | 2026-09-15 |
| Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies T-cell therapy + Rituximab + IL-2 - B-Cell Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | Unknown | National University Hospital, Singapore | 18 | 2014-12-01 | 2016-06-22 |
Breast Neoplasms (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1)
David Avigan (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · National University Hospital, Singapore (1)
United States (2) · Singapore (1)
David Avigan, MD (1) · Heather Han, MD (1) · Michelle Poon, MBBS, MRCP (1) · Yeh Ching Linn, MBBS, MRCP (1)
2014 (1)